DHR
LONGINSIDER SELLDANAHER CORP DEL
Research: Finviz ↗·Perplexity ↗
🗄 Viewing archived Q2 2026 data — frozen, no longer refreshed.
News Summary
PositiveDanaher delivered consecutive earnings beats in Q2 and Q3 2026 with strong revenue growth (5.5% and 8.5% YoY respectively), raised full-year EPS guidance twice, and successfully closed the Masimo acquisition ahead of schedule. Life Sciences and Diagnostics segments showed robust performance, though Q3 core revenue growth excluding respiratory was 5.5%, indicating some underlying moderation in core business momentum.
Red flags
- •Q3 core revenue growth (5.5% ex-respiratory) decelerating from Q2 core growth rate of 3-4%, suggesting potential underlying momentum loss in key segments
- •Respiratory testing headwind of 250 bps in Q3 guidance, indicating reliance on a volatile/declining product category
- •Some analyst caution noted on valuation with higher discount rates and conservative margin assumptions in life sciences tools sector
Funds Buying (5)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Glenview Capital | Larry Robbins | 1.1M | +990K | $218M | 4.4% | +633% | Existing |
| Third Point | Dan Loeb | 540K | +15K | $103M | 2.2% | +3% | Existing |
| Tiger Global | Chase Coleman | 456K | +456K | $87M | 0.4% | — | NEW |
| Duquesne Family Office | Stanley Druckenmiller | 50K | +50K | $10M | 0.2% | — | NEW |
| Point72 | Steve Cohen | 11K | +11K | $2M | <0.1% | — | NEW |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.
Portfolio Context
Where DHR ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.
position #7 of this fund's book
- 4THERMO FISHER SCIENTIFIC INC$314M
- 5AMAZON COM INC$303M
- 6AGILENT TECHNOLOGIES INC$262M
- 7DANAHER CORP DEL$218M
- 8META PLATFORMS INC$201M
- 9ADVANCED MICRO DEVICES INC$173M
- 10TEVA PHARMACEUTICAL INDS LTD$172M
position #19 of this fund's book
- 16API GROUP CORP$121M
- 17MASTEC INC$121M
- 18TRANSDIGM GROUP INC$105M
- 19DANAHER CORP DEL$103M
- 20UNION PAC CORP$95M
- 21TTM TECHNOLOGIES INC$94M
- 22PERFORMANCE FOOD GROUP CO$75M
position #32 of this fund's book
- 29CHIME FINL INC$108M
- 30EQUIPMENTSHARE COM INC$90M
- 31SHERWIN WILLIAMS CO$89M
- 32DANAHER CORP DEL$87M
- 33SERVICENOW INC$87M
- 34SPACE EXPLORATION TECHN CORP$64M
- 35WEBULL CORP$44M
Values are quarter-end position sizes. Shown only for funds where DHR ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.
Signal History
Same issuer appearing in consecutive quarters — persistent institutional conviction. Returns are frozen at each archived quarter's last refresh.
Insider Activity
| Name | Title | Type | Shares | Price | Value | Filed | Src |
|---|---|---|---|---|---|---|---|
| McGrew Matthew | Executive Vice President | SELL | 17K | $235.69 | $4.10M | 2026-11-09 | ↗ |
| Milosevich Gregory M | Executive Vice President | SELL | 2K | $230.62 | $0.48M | 2026-11-09 | ↗ |
| Bouda Christopher | VP, Chief Accounting Officer | SELL | 4K | $234.54 | $1.02M | 2026-10-28 | ↗ |
| Bouda Christopher | VP, Chief Accounting Officer | SELL | 3K | $234.58 | $0.76M | 2026-10-28 | ↗ |
| McGrew Matthew | Executive Vice President | SELL | 14K | $235.35 | $3.33M | 2026-10-28 | ↗ |
| McGrew Matthew | Executive Vice President | SELL | 16K | $236.09 | $3.68M | 2026-10-28 | ↗ |
| Blair Rainer | President & CEO | SELL | 11K | $217.77 | $2.46M | 2026-08-21 | ↗ |
| Blair Rainer | President & CEO | SELL | 39K | $218.73 | $8.57M | 2026-08-21 | ↗ |
| Blair Rainer | President & CEO | SELL | 8K | $219.35 | $1.70M | 2026-08-21 | ↗ |
Beneficial Ownership (13D/13G)
| Filer | Form | Shares | % of Class | Filed | Src |
|---|---|---|---|---|---|
| FMR LLC | SC 13G | 39.2M | 5.6% | 2026-11-05 | ↗ |
| Vanguard Capital Management | SC 13G | 47.4M | 6.7% | 2026-04-29 | ↗ |
SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.
Congressional Trading
No trades dated since Apr 1, 2026.
Earlier trades (1) — dated outside this quarter's window, not counted in the badges
| Member | Chamber | State | Type | Amount Range | Transaction Date | Filed | Src |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | senate | — | BUY | $1,001 - $15,000 | 2026-03-27 | 2026-07-21 | ↗ |
Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures. Members often file weeks or months after trading, so trades are placed by transaction date: the badges above count trades dated since Apr 1, 2026.